9342-8530 Quebec Inc DGCRF

RE: going, going, gone

[ready2go1]

Gen-Probe is a hot company from what I am reading and what makes them so attractive is their new pipeline. The stories that I have read talk about the two tests that they have currently in front of the FDA and of course, one of them is PCA3. There is belief that GPRO could get $5.8 billion, and its not because the "Holy Grail" of prostate cancer testing is going to bring in $30 to $50 million a year. Opinion leaders who I have spoken with continue to point >$100 million and growing. They list several key factors, many of which have been discussed at ASCO and EU.
     Problem with CUR is that the share price is news driven. Drifts down without news and will run with it. Shortly this board will pop with all kind of new posters once the news breaks. I am even more confident of a break out from here of at least 400%, but still would like to see us push to a 52 week high prior to news.